Revolution Medicines stockholders elect directors, ratify auditor, approve say-on-pay at annual meeting

Revolution Medicines, Inc.

Elected three Class II directors: Sushil Patel, Eric Schmidt, Thilo Schroeder with substantial support.
Ratified PricewaterhouseCoopers LLP as independent auditor for fiscal 2022 (62.1M for, 6,377 against).
Advisory approval of named executive officer compensation (53.4M for, 4.6M against, broker non-votes 4.1M).
Advisory vote favored holding future say-on-pay votes annually (57.8M for one year); company will adopt annual frequency.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.